Genes & Genomics

, Volume 41, Issue 12, pp 1493–1503 | Cite as

Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer

  • Songbai Liao
  • Minglin Ou
  • Liusheng Lai
  • Hua Lin
  • Yaoshuang Zou
  • Yonggang Yu
  • Xuede Li
  • Yong Dai
  • Weiguo SuiEmail author
Research Article



Bladder cancer (BCa) is a tumor associated with high morbidity and mortality and its incidence is increasing worldwide. However, the pathogenesis of bladder cancer is not well understood.


To further illustrate the molecular mechanisms involved in the pathogenesis of BCa and identify potential therapeutic targets, we combined the transcriptomic analysis with RNA sequencing and tandem mass tags (TMT)-based proteomic methods to quantitatively screen the differentially expressed genes and proteins between bladder cancer tissues (BC) and adjacent normal tissues (AN).


Transcriptome and proteome studies indicated 7094 differentially expressed genes (DEGs) and 596 differentially expressed proteins (DEPs) between BC and AN, respectively. GO enrichment analyses revealed that cell adhesion, calcium ion transport, and regulation of ATPase activity were highly enriched in BCa. Moreover, several key signaling pathway were identified as of relevance to BCa, in particular the ECM-receptor interaction, cell adhesion molecules (CAMs), and PPAR signaling pathway. Interestingly, 367 genes were shared by DEGs and DEPs, and a significant positive correlation between mRNA and translation profiles was found.


In summary, this joint analysis of transcript and protein profiles provides a comprehensive reference map of gene activity regarding the disease status of BCa.


Bladder cancer RNA sequencing Proteomic 



We wish to thank the patients for their invaluable participation in this study. This work was supported by Project Plan Document of Guangxi Key Laboratory Construction (17-259-57), and Science and Technology Planning Project of Guangdong Province, China (No. 2017B020209001).

Compliance with ethical standards

Conflict of interest

Songbai Liao, Minglin Ou, Liusheng Lai, Hua Lin, Yaoshuang Zou, Yonggang Yu, Xuede Li, Yong Dai, and Weiguo Sui declare that they have no conflict of interest.

Supplementary material

13258_2019_868_MOESM1_ESM.doc (22 kb)
Supplementary material 1 (DOC 22 kb)
13258_2019_868_MOESM2_ESM.xlsx (902 kb)
Supplementary material 2 (XLSX 902 kb)
13258_2019_868_MOESM3_ESM.csv (120 kb)
Supplementary material 3 (CSV 120 kb)
13258_2019_868_MOESM4_ESM.csv (11 kb)
Supplementary material 4 (CSV 11 kb)


  1. Blake JA, Dolan M, Drabkin H, Hill DP, Li N, Sitnikov D, Bridges S, Burgess S, Buza T, McCarthy F et al (2013) Gene ontology annotations and resources. Nucleic Acids Res 41:D530–D535PubMedGoogle Scholar
  2. Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics 30:2114–2120CrossRefGoogle Scholar
  3. Chang HY, Chang HM, Wu TJ, Chaing CY, Tzai TS, Cheng HL, Raghavaraju G, Chow NH, Liu HS (2017) The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis. J Biomed Sci 24:61CrossRefGoogle Scholar
  4. Chen H, Lin H, Xu M, Xu G, Fang X, He L, Chen Z, Wu Z, Geng H (2018) Quantitative Urinary Proteome Reveals Potential Biomarkers for Ureteropelvic Junction Obstruction. Proteomics Clin Appl 13:e1800101CrossRefGoogle Scholar
  5. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367–1372CrossRefGoogle Scholar
  6. Gao X, Chen Y, Chen M, Wang S, Wen X, Zhang S (2018) Identification of key candidate genes and biological pathways in bladder cancer. PeerJ 6:e6036CrossRefGoogle Scholar
  7. Garg M (2015) Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer Metastasis Rev 34:691–701CrossRefGoogle Scholar
  8. Hou X, Liang Y, Chen J, Wei Y, Zeng P, Wang L, Lu C, Diao H (2017) Expression profiling of cellular microRNA in asymptomatic HBsAg carriers and chronic hepatitis B patients. Biomed Res Int 2017:6484835PubMedPubMedCentralGoogle Scholar
  9. Ismail AF, Oskay HS, Babteen N, De Piano M, Martin TA, Jiang WG, Khan MS, Dasgupta P, Wells CM (2017) PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells. Biochem J 474:1333–1346CrossRefGoogle Scholar
  10. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30CrossRefGoogle Scholar
  11. Khorramdelazad H, Bagheri V, Hassanshahi G, Karami H, Moogooei M, Zeinali M, Abedinzadeh M (2015) S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression? Asian Pac J Cancer Prev 16:2725–2729CrossRefGoogle Scholar
  12. Li WV, Li JJ (2018) An accurate and robust imputation method scImpute for single-cell RNA-seq data. Nat Commun 9:997CrossRefGoogle Scholar
  13. Li W, Liu J, Zou D, Cai X, Wang J, Wang J, Zhu L, Zhao L, Ou R, Xu Y (2017) Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network. Oncol Rep 37:1461–1468CrossRefGoogle Scholar
  14. Li Z, Fu J, Li N, Shen L (2018) Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 505:274–281CrossRefGoogle Scholar
  15. Lin Z, Wang Z, Zhang X, Liu Z, Li G, Wang S, Ding Y (2017) Complementary proteome and transcriptome profiling in developing grains of a notched-belly rice mutant reveals key pathways involved in chalkiness formation. Plant Cell Physiol 58:560–573CrossRefGoogle Scholar
  16. Lou X, Wang H, Ni X, Gao Z, Iqbal S (2018) Integrating proteomic and transcriptomic analyses of loquat (Eriobotrya japonica Lindl.) in response to cold stress. Gene 677:57–65CrossRefGoogle Scholar
  17. Lu Y, Liu P, Wen W, Grubbs CJ, Townsend RR, Malone JP, Lubet RA, You M (2010) Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models. Am J Transl Res 3:8–27PubMedPubMedCentralGoogle Scholar
  18. Marin-Aguilera M, Mengual L, Ribal MJ, Ars E, Rios J, Gazquez C, Villavicencio H, Alcaraz A (2012) Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer. Urology 79:240–249CrossRefGoogle Scholar
  19. Matsumoto M, Kawakami K, Enokida H, Toki K, Matsuda R, Chiyomaru T, Nishiyama K, Kawahara K, Seki N, Nakagawa M (2010) CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer. Int J Mol Med 26:241–247PubMedGoogle Scholar
  20. Munksgaard PP, Mansilla F, Brems EA, Fristrup N, Birkenkamp-Demtroder K, Ulhoi BP, Borre M, Agerbaek M, Hermann GG, Orntoft TF, Dyrskjot L (2011) Low ANXA10 expression is associated with disease aggressiveness in bladder cancer. Br J Cancer 105:1379–1387CrossRefGoogle Scholar
  21. Na XY, Shang XS, Zhao Y, Ren PP, Hu XQ (2018) MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4. Neoplasma 66:211–221CrossRefGoogle Scholar
  22. Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL (2016) Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc 11:1650–1667CrossRefGoogle Scholar
  23. Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsbergen-van DKC, Besenbacher S et al (2011) European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet 20:4268–4281CrossRefGoogle Scholar
  24. Sokolov I, Dokukin ME, Kalaparthi V, Miljkovic M, Wang A, Seigne JD, Grivas P, Demidenko E (2018) Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: detection of bladder cancer. Proc Natl Acad Sci USA 115:12920–12925CrossRefGoogle Scholar
  25. Wang S, Chen W, Yang C, Yao J, Xiao W, Xin Y, Qiu J, Hu W, Yao H, Ying W et al (2016) Comparative proteomic analysis reveals alterations in development and photosynthesis-related proteins in diploid and triploid rice. BMC Plant Biol 16:199CrossRefGoogle Scholar
  26. Wang Y, Shi F, Xia Y, Zhao H (2018) LncRNA OIP5-AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer. J Cell Biochem. CrossRefPubMedPubMedCentralGoogle Scholar
  27. Wei S, Fukuhara H, Kawada C, Kurabayashi A, Furihata M, Ogura S, Inoue K, Shuin T (2015) Silencing of ATPase inhibitory factor 1 inhibits cell growth via cell cycle arrest in bladder cancer. Pathobiology 82:224–232CrossRefGoogle Scholar
  28. Wen X, Franchi L, Chen F, Gu Y (2018) Proteomic analysis of gingival crevicular fluid for novel biomarkers of pubertal growth peak. Eur J Orthod 40:414–422CrossRefGoogle Scholar
  29. Werntz RP, Adamic B, Steinberg GD (2018) Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC). World J Urol. CrossRefPubMedGoogle Scholar
  30. Zhou J, Dong D, Cheng R, Wang Y, Jiang S, Zhu Y, Fan L, Mao X, Gui Y, Li Z et al (2016) Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer. Oncotarget 7:72767–72776PubMedPubMedCentralGoogle Scholar

Copyright information

© The Genetics Society of Korea 2019

Authors and Affiliations

  1. 1.The First School of Clinical MedicineSouthern Medical UniversityGuangdongChina
  2. 2.Guangxi Key Laboratory of Metabolic Diseases Research, Affiliated No.924 Military HospitalSouthern Medical UniversityGuangxiChina
  3. 3.Department of Urology, Affiliated No.924 Military HospitalSouthern Medical UniversityGuangxiChina
  4. 4.Clinical Medical Research CenterThe Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital)ShenzhenPeople’s Republic of China

Personalised recommendations